XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
XRP Regulatory Milestone in Canada, ETF Options Hit US Market
The core claim is that XRP has secured another regulatory milestone in Canada. The reporting does not name the Canadian authority that acted, the entity or prod...
Bitcoin ETF Outflows Contrast With XRP Fund Inflow Streak
US spot Bitcoin ETFs bled $282. 7 million on September 10, 2026, a third straight negative session, even as XRP funds logged another day of inflows and extended...
Lummis: Clarity Act Has 100+ Democrat-Requested Changes
Senator Cynthia Lummis says the latest text of the Clarity Act carries more than 100 changes requested by Democrats, a claim that frames the bill’s newest revis...
Sam Bankman-Fried Petitions Supreme Court in FTX Fraud Case
The development, as reported by BeInCrypto , is that Bankman-Fried is seeking Supreme Court review of his fraud case. The details available at this stage are li...
XRP Healthcare Winds Down After Roughly $450K Wallet Theft
XRP Healthcare is winding down after an XRP Healthcare wallet flaw led to roughly $450,000 being drained from about 4,010 wallets, according to a developer inci...
Consensys Plans MetaMask Separation by Year-End
Consensys said on September 9, 2026 that it plans to separate its consumer wallet business, MetaMask, from its blockchain infrastructure operations, with the sp...
